Advertisement
NRC vs UPBD
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NRC is a Buy and UPBD is a Hold.
NRC sees its Stochastic Oscillator ascends from oversold territory
On October 15, 2026, the Stochastic Oscillator for NRC moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 61 instances where the indicator left the oversold zone. In 47 of the 61 cases the stock moved higher in the following days. This puts the odds of a move higher at over 77%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 20, 2026. You may want to consider a long position or call options on NRC as a result. In 58 of 99 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 59%.
The Moving Average Convergence Divergence (MACD) for NRC just turned positive on October 15, 2026. Looking at past instances where NRC's MACD turned positive, the stock continued to rise in 34 of 48 cases over the following month. The odds of a continued upward trend are 71%.
Following a +2.68% 3-day Advance, the price is estimated to grow further. Considering data from situations where NRC advanced for three days, in 210 of 295 cases, the price rose further within the following month. The odds of a continued upward trend are 71%.
NRC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
NRC moved below its 50-day moving average on October 16, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for NRC crossed bearishly below the 50-day moving average on September 29, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 7 of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 50%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where NRC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 77%.
The Aroon Indicator for NRC entered a downward trend on October 02, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 2 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 26 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 40 (best 1 - 100 worst), indicating steady price growth. NRC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 92 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: NRC's P/B Ratio (68.598) is very high in comparison to the industry average of (4.100). NRC's P/E Ratio (84.625) is considerably higher than the industry average of (13.263). Projected Growth (PEG Ratio) (2.150) is also within normal values, averaging (2.133). Dividend Yield (0.032) settles around the average of (0.012) among similar stocks. P/S Ratio (3.460) is also within normal values, averaging (6.065).
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NRC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 97, placing this stock worse than average.
UPBD's RSI Indicator ascending out of oversold territory
The RSI Indicator for UPBD moved out of oversold territory on October 07, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 34 similar instances when the indicator left oversold territory. In 24 of the 34 cases the stock moved higher. This puts the odds of a move higher at 71%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 12, 2026. You may want to consider a long position or call options on UPBD as a result. In 55 of 83 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 66%.
The Moving Average Convergence Divergence (MACD) for UPBD just turned positive on October 07, 2026. Looking at past instances where UPBD's MACD turned positive, the stock continued to rise in 26 of 40 cases over the following month. The odds of a continued upward trend are 65%.
Following a +6.78% 3-day Advance, the price is estimated to grow further. Considering data from situations where UPBD advanced for three days, in 184 of 271 cases, the price rose further within the following month. The odds of a continued upward trend are 68%.
Bearish Trend Analysis
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 45 of 53 cases where UPBD's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 85%.
The 50-day moving average for UPBD moved below the 200-day moving average on October 02, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where UPBD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 73%.
UPBD broke above its upper Bollinger Band on October 15, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for UPBD entered a downward trend on October 12, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 34 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.285) is normal, around the industry mean (-1.402). P/E Ratio (10.299) is within average values for comparable stocks, (14.914). Projected Growth (PEG Ratio) (0.380) is also within normal values, averaging (2.824). Dividend Yield (0.096) settles around the average of (0.072) among similar stocks. P/S Ratio (0.220) is also within normal values, averaging (71.128).
The Tickeron SMR rating for this company is 62 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 63 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 72 (best 1 - 100 worst), indicating slightly worse than average price growth. UPBD’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. UPBD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
NRC | UPBD | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 34 | 17 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 92 Overvalued | 34 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 26 | 62 | |
PRICE GROWTH RATING 1..100 | 40 | 72 | |
P/E GROWTH RATING 1..100 | 2 | 63 | |
SEASONALITY SCORE 1..100 | n/a | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
UPBD's Valuation (34) in the Finance Or Rental Or Leasing industry is somewhat better than the same rating for NRC (92) in the Servicestothe Health Industry industry. This means that UPBD’s stock grew somewhat faster than NRC’s over the last 12 months.
UPBD's Profit vs Risk Rating (100) in the Finance Or Rental Or Leasing industry is in the same range as NRC (100) in the Servicestothe Health Industry industry. This means that UPBD’s stock grew similarly to NRC’s over the last 12 months.
NRC's SMR Rating (26) in the Servicestothe Health Industry industry is somewhat better than the same rating for UPBD (62) in the Finance Or Rental Or Leasing industry. This means that NRC’s stock grew somewhat faster than UPBD’s over the last 12 months.
NRC's Price Growth Rating (40) in the Servicestothe Health Industry industry is in the same range as UPBD (72) in the Finance Or Rental Or Leasing industry. This means that NRC’s stock grew similarly to UPBD’s over the last 12 months.
NRC's P/E Growth Rating (2) in the Servicestothe Health Industry industry is somewhat better than the same rating for UPBD (63) in the Finance Or Rental Or Leasing industry. This means that NRC’s stock grew somewhat faster than UPBD’s over the last 12 months.
| NRC | UPBD | |
|---|---|---|
| RSI ODDS (%) | N/A | 2 days ago 71% |
| Stochastic ODDS (%) | 2 days ago 77% | 2 days ago 85% |
| Momentum ODDS (%) | 2 days ago 59% | 2 days ago 66% |
| MACD ODDS (%) | 2 days ago 71% | 2 days ago 65% |
| TrendWeek ODDS (%) | 2 days ago 76% | 2 days ago 69% |
| TrendMonth ODDS (%) | 2 days ago 72% | 2 days ago 73% |
| Advances ODDS (%) | 3 days ago 71% | 8 days ago 68% |
| Declines ODDS (%) | 28 days ago 77% | 4 days ago 73% |
| BollingerBands ODDS (%) | 2 days ago 71% | 2 days ago 85% |
| Aroon ODDS (%) | 2 days ago 80% | 2 days ago 81% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
NRC’s FA Score shows that 2 FA rating(s) are green while UPBD’s FA Score has 0 green FA rating(s).
- NRC’s FA Score: 2 green, 3 red.
- UPBD’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
NRC’s TA Score shows that 5 TA indicator(s) are bullish while UPBD’s TA Score has 4 bullish TA indicator(s).
- NRC’s TA Score: 5 bullish, 4 bearish.
- UPBD’s TA Score: 4 bullish, 5 bearish.
Price Growth
NRC (@Services to the Health Industry) experienced а -0.59% price change this week, while UPBD (@Packaged Software) price change was +4.73% for the same time period.
The average weekly price growth across all stocks in the @Services to the Health Industry industry was -1.51%. For the same industry, the average monthly price growth was -3.63%, and the average quarterly price growth was +16.27%.
The average weekly price growth across all stocks in the @Packaged Software industry was -0.43%. For the same industry, the average monthly price growth was -3.98%, and the average quarterly price growth was +4.31%.
Reported Earning Dates
NRC is expected to report earnings on Oct 26, 2026.
UPBD is expected to report earnings on Oct 29, 2026.
Industries' Descriptions
@Services to the Health Industry (-1.51% weekly)This industry comprises companies that provide services, such as equipment sterilization, research, physician management systems and consulting, that support the healthcare/medical industry. Examples of such companies include Laboratory Corporation of America Holdings, which operates one of the largest clinical laboratory networks in the world; Quest Diagnostics Inc., which is a clinical laboratory; and Syneos Health, which is a major clinical research organization.
@Packaged Software (-0.43% weekly)Packaged software comprises multiple software programs bundled together and sold as a group. For example, Microsoft Office includes multiple applications such as Excel, Word, and PowerPoint. In some cases, buying a bundled product is cheaper than purchasing each item individually[s20] . Microsoft Corporation, Oracle Corp. and Adobe are some major American packaged software makers.
Advertisement
NRC and
Correlation & Price change
A.I.dvisor indicates that over the last year, NRC has been loosely correlated with UPBD. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if NRC jumps, then UPBD could also see price increases.
| Ticker / NAME | Correlation To NRC | 1D Price Change % | ||
|---|---|---|---|---|
| NRC | 100% | -1.84% | ||
| UPBD - NRC | 46% Loosely correlated | -0.92% | ||
| DOX - NRC | 42% Loosely correlated | +0.31% | ||
| DJCO - NRC | 41% Loosely correlated | -2.07% | ||
| QLYS - NRC | 41% Loosely correlated | +3.27% | ||
| EEFT - NRC | 40% Loosely correlated | -0.35% | ||
More | ||||